GlassScriptPhysician profile
George J Murillo
NPI 1568426153
$830.77
in general payments reported to CMS, 2019-2025
17 companies · $60.00 in 2025
The $60.00 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.75 · 2021: $16.45 · 2022: $269 · 2023: $300 · 2024: $164 · 2025: $60.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $524.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $523.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $149.05 | 2022-2024 | Otezla, Repatha |
| Novo Nordisk INC | $135.23 | 2023-2024 | Wegovy, Ozempic, Rybelsus |
| Teva Pharmaceuticals USA, INC. | $74.73 | 2023-2025 | Austedo Xr, Austedo, Austedo Xr |
| Astrazeneca Pharmaceuticals LP | $67.11 | 2021-2022 | |
| Abbvie INC. | $65.46 | 2022-2023 | |
| Pfizer INC. | $52.97 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $49.92 | 2022 | |
| Jazz Pharmaceuticals INC. | $32.43 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.80 | 2024-2025 | Xifaxan |
| Lilly USA, LLC | $31.32 | 2022-2024 | Zepbound, Mounjaro |
| Abbott Laboratories | $24.95 | 2025 | Freestyle Libre 3 |
| Paratek Pharmaceuticals, INC. | $22.91 | 2024 | Nuzyra |
| Sanofi-Aventis U.S. LLC | $21.75 | 2019 | |
| Kyowa Kirin, INC. | $21.24 | 2024 | Crysvita |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.80 | 2024 | Jardiance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $17.12 | 2023 | Closurefast |
| Otsuka America Pharmaceutical, INC. | $12.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Murillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.